CU

Christian Uhrich

Investment Director, Biotechnology Investments

Karlsruhe, Baden-Württemberg

Invests in

Sectors:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Investment Director, Biotechnology Investments

    2021

  • Head of Strategy

    2019 - 2021

2024

  • Board Observer

    2024

  • Member Board of Directors

    2023

2023

  • Member Board of Directors

    2023

2023

  • Board Observer

    2023

  • Member Board of Directors

    2022

2022

  • Member Board of Directors

    2022

2022

  • Board Observer

    2022

  • Board Observer

    2022

2021 - 2022

  • Member Board of Directors

    2021 - 2022

    Riffyn was acquired by Siemens and integrated into the Siemens Life Science offerings as Riffyn X in 2022.